Trexquant Investment’s Arcturus Therapeutics ARCT Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q4	–	Sell	-74,424	Closed	-$1.73M	–	1539
2024 Q3	$1.73M	Buy	74,424 +21,015	+39%	+$450K	0.02%	868
2024 Q2	$1.3M	Buy	+53,409	New	+$1.62M	0.02%	912
2024 Q1	–	Sell	-10,956	Closed	-$345K	–	1419
2023 Q4	$345K	Sell	10,956 -40,915	-79%	-$972K	0.01%	1210
2023 Q3	$1.33M	Buy	51,871 +17,230	+50%	+$531K	0.03%	642
2023 Q2	$994K	Buy	+34,641	New	+$943K	0.03%	762
2023 Q1	–	Sell	-21,284	Closed	-$361K	–	1424
2022 Q4	$361K	Buy	+21,284	New	+$371K	0.01%	1040
2022 Q1	–	Sell	-5,939	Closed	-$220K	–	1330
2021 Q4	$220K	Buy	+5,939	New	+$242K	0.01%	1100
2021 Q2	–	Sell	-5,428	Closed	-$224K	–	1076
2021 Q1	$224K	Buy	+5,428	New	+$324K	0.02%	916
2020 Q2	–	Sell	-12,632	Closed	-$172K	–	1150
2020 Q1	$172K	Buy	+12,632	New	+$162K	0.01%	997